PRA Group, Inc. Form 8-K Summary
Business Context and Reporting Period
PRA Group, Inc. (NASDAQ: PRAA), a provider of clinical research services, filed this Current Report on Form 8-K on August 8, 2019. The filing serves to announce the Company's financial results for the second quarter of 2019.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this Form 8-K.
Material Changes
No specific material changes versus the prior comparable period are quantified in this filing. The document solely references the issuance of the second quarter 2019 results press release.
Guidance, Outlook, and Management Commentary
Management commentary and any updated guidance are located in the press release (Exhibit 99.1) and the slide presentation used for the August 8, 2019, webcast and conference call. The slide presentation is available on the Company's Investor Relations website. The filing explicitly states that the information in Items 2.02, 7.01, and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 8, 2019) for specific Q2 2019 revenue, net income, and earnings per share figures.
- Access the slide presentation at https://ir.pragroup.com/events-and-presentations for management's outlook and strategic commentary.
- Verify the Company's liquidity position and debt levels in the full press release, as they are not listed in this summary filing.
- Note that the information in this 8-K is for disclosure purposes only and carries specific legal disclaimers regarding liability under Section 18.